COVID-19 Vaccine Trial Articles from The Lancet Journals
This classification groups linked clinical-trial reports on the safety and immunogenicity of COVID-19 vaccines published in The Lancet and The Lancet Infectious Diseases, including studies of adenovirus-vectored and inactivated vaccines.
0
1
Tags
SARS-CoV-2 (COVID-19)
Biomedical engineering
Biomedical Sciences
Related
Biomedical Engineering for COVID-19 Articles from the Nature Biomedical Engineering Journal
Biomedical Engineering for COVID-19 Articles from the Immunity Journal
Biomedical Engineering for COVID-19 Articles from the Nature Biotechnology Journal
Biomedical Engineering for COVID-19 Articles from the Annals of Internal Medicine
Biomedical Engineering for COVID-19 Articles from Wikipedia
Biomedical Engineering for COVID-19 Articles from SSRN Electronic Journal
Biomedical Engineering for COVID-19 Articles from the BioRxiv Journal
Biomedical Engineering for COVID-19 Articles from Human Vaccines & Immunotherapeutics
Biomedical Engineering for COVID-19 Articles from De Gruyter
Biomedical Engineering for COVID-19 Articles from the Diagnostics Journal
Biomedical Engineering for COVID-19 Articles from the Frontiers in Cell and Developmental Biology Journal
Biomedical Engineering for COVID-19 Articles from Nature Nanotechnology
Biomedical Engineering for COVID-19 Articles from the CDC
Biomedical Engineering for COVID-19 Articles from Chaos, Solitons, and Fractals
Biomedical Engineering for COVID-19 Articles from European Journal of Clinical Microbiology and Infectious Diseases
Biomedical Engineering for COVID-19 Articles from SN Computer Science
Biomedical Engineering for COVID-19 Articles from TH open: companion journal to thrombosis and haemostasis
Biomedical Engineering for COVID-19 Articles from Life Sciences
Biomedical Engineering for COVID-19 Articles from The New York Times
Biomedical Engineering for COVID-19 Articles from the Cell Journal
Biomedical Engineering for COVID-19 Articles from National Institutes of Health
Biomedical Engineering for COVID-19 Articles from Chinese News
Biomedical Engineering for COVID-19 Articles from U.S. National Library of Medicine
Biomedical Engineering for COVID-19 Articles from the Theranostics Journal
Biomedical Engineering for COVID-19 Articles from the Elsevier Journal
Biomedical Engineering for COVID-19 Articles from the JAMA Network
Biomedical Engineering for COVID-19 Articles from Computers in Biology and Medicine
Biomedical Engineering for COVID-19 Articles from The New England Journal of Medicine
Biomedical Engineering for COVID-19 Articles from the Journal of Clinical Virology
Biomedical Engineering for COVID-19 Articles from Nature Public Health Emergency Collection
Biomedical Engineering for COVID-19 Articles from medRxiv
Biomedical Engineering for COVID-19 Articles from Nature, Nature Communications, and Pediatric Research
COVID-19 Vaccine Trial Articles from The Lancet Journals
COVID-19 Biomedical Engineering References from Pfizer
Learn After
Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial.
Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial
Immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older: a randomised, double-blind, placebo-controlled, phase 2 trial
Safety and immunogenicity of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine in two formulations: two open, non randomised phase 1/2 studies from Russia
Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBIBP-CorV: a randomised, double-blind, placebo-controlled, phase 1/2 trial